AlzeCure Pharma

AlzeCure Pharma is a Stockholm based company. AlzeCure Pharma has a highly experienced team of experts in drug discovery and early development, working on innovative projects  to deliver new therapies for the treatment of neurological disorders such as Alzheimer's disease.

AlzeCure Pharma AB is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe disorders that affect the central nervous system, such as Alzheimer’s disease and pain-indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallell drug candidates based on the three research platforms, NeuroRestore®, Alzstatin® and Painless.